knownwell’s Post

View organization page for knownwell

10,706 followers

Our Co-Founder and Chief Medical Officer Angela Fitch MD, FACP, MFOMA, Dipl. ABOM joined CBS Mornings to discuss the latest FDA decision to tell companies to halt production of compounded GLP-1s and the dangers of patients taking these substandard compounded medications without full knowledge of the implications or effects. Watch the full clip below! https://lnkd.in/eGkxtg8F

What possible compounded semaglutide ban means for patients

What possible compounded semaglutide ban means for patients

cbsnews.com

Bridget Slusarek DNP, MBA, RN

Innovative Healthcare Leader l Strategic Advisor l Chronic Disease Management, and Obesity Expert l Leadership and Development l DNP, MBA, RN l Executive Nursing Leadership

4mo

This interview was an insightful discussion regarding gaps in obesity treatment. Well done, Dr. Fitch!

To view or add a comment, sign in

Explore topics